Mario Cazzola
Università degli Studi di Pavia
H-index: 136
Europe-Italy
Top articles of Mario Cazzola
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes | Blood Journal | Maria Sirenko Elsa Bernard Maria Creignou Dylan Domenico Andrea Farina | 2024/4/30 |
International Consensus Classification for myeloid neoplasms at‐a‐glance | Attilio Orazi Robert P Hasserjian Mario Cazzola Hartmut Döhner Ayalew Tefferi | 2023/1 | |
UBA1 Mutations Identify a Rare but Distinct Subtype of Myelodysplastic Syndromes | Blood | Maria Sirenko Elsa Bernard Maria Creignou Dylan Domenico Andrea Farina | 2023/11/28 |
Introduction to a review series on germ line predisposition to hematologic malignancies: time to consider germ line testing | Blood | Mario Cazzola | 2023/3/30 |
Molecular Taxonomy of Myelodysplastic Syndromes and Its Clinical Implications | Blood | Elsa Bernard Robert Hasserjian Peter L Greenberg Juan E Arango Ossa Maria Creignou | 2023/11/28 |
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms | Blood | Christian Pecquet Nicolas Papadopoulos Thomas Balligand Ilyas Chachoua Amandine Tisserand | 2023/2/23 |
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41 | Blood Advances | Claire C Homan Michael W Drazer Kai Yu David M Lawrence Jinghua Feng | 2023/10/24 |
Germ line DDX41 mutations define a unique subtype of myeloid neoplasms | Blood | Hideki Makishima Ryunosuke Saiki Yasuhito Nannya Sophia Korotev Carmelo Gurnari | 2023/2/2 |
Introduction to a review series on myelodysplastic syndromes in the age of genomic medicine | Mario Cazzola | 2023/12/28 | |
Introduction to a review series on classic myeloproliferative neoplasms | Blood | Mario Cazzola | 2023/4/20 |
Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: A STEP TOWARDS IDENTIFICATION AND CAUSAL INTERPRETATION OF THERAPY-RELATED MDS (T-MDS) | Leukemia Research | T Silzle A Taylor T De Witte L Malcovati P Fenaux | 2021/9/1 |
The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients | Blood cancer journal | Tiziano Barbui Alessandra Carobbio Juergen Thiele Naseema Gangat Elisa Rumi | 2023/12/15 |
Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): GENOMIC CLASSIFICATION OF MYELODYSPLASTIC SYNDROMES | Leukemia Research | C Cargo R Ali D Payne P Glover S Van Hoppe | 2023/5/1 |
Implementation and adoption of a web tool to support precision diagnostic and treatment decisions for patient with myelodysplastic syndromes | Cancer Research | Elsa Bernard Juan E Arango Ossa Heinz Tuechler Peter L Greenberg Robert P Hasserjian | 2023/4/4 |
The Significance of Variant Allele Frequency in SF3B1 Mutated Myelodysplastic Neoplasms/Syndromes | Blood | Curtis A Lachowiez Georgios Asimomitis Elsa Bernard Ivory Tang Maria Creignou | 2023/11/28 |
PD‐L1 overexpression correlates with JAK2‐V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms | American Journal of Hematology | Jelena D Milosevic Feenstra Roland Jäger Fiorella Schischlik Daniel Ivanov Gregor Eisenwort | 2022/4 |
P741: DDX41 MUTATIONS DEFINE A UNIQUE SUBTYPE OF MYELOID NEOPLASMS. | HemaSphere | H Makishima R Saiki Y Nannya S Korotev C Gurnari | 2022/6 |
Response to “The WHO classification of haematolymphoid tumours” | Leukemia | Steven H Swerdlow Elias Campo Daniel A Arber Mario Cazzola James R Cook | 2022/11 |
RNA missplicing and ring sideroblasts in MDS | Blood, The Journal of the American Society of Hematology | Mario Cazzola | 2022/3/31 |
Developing a classification of hematologic neoplasms in the era of precision medicine | Blood, The Journal of the American Society of Hematology | Mario Cazzola Laurie H Sehn | 2022/9/15 |
Co-Authors
